Neoadjuvant chemo shows mixed results in PCa

June 1, 2004

San Francisco--Continuing a trend of mixed results seen in previousstudies, neoadjuvant chemotherapy with docetaxel (Taxotere) resulted ina significant PSA response but failed to induce any histologic changes inlocally advanced prostate cancer, Cleveland Clinic investigators reportedat the AUA annual meeting.

Related Content:

News | Pediatrics | Drug Therapy